Selected Publications
Amado DA, Robbins AB, Smith AR, Whiteman KR, Chillon G, Chen Y, Fuller JA, Izda A, Nelson S, Dichter AI, Monteys AM, Davidson BL.: AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS. bioRxiv : 2024.
Morganroth J, Baer M, Amado DA, Quinn C, Ackrivo J, Elman L.: Expanding ALS Clinical Trial Eligibility by Using Transcutaneous CO2. Northeast ALS Consortium Annual Meeting, Clearwater, FL, October 2023. : 2023.
Dratch L, Azage M, Baldwin A, Bardakjian TM, Johnson K, Paul RA, Babaian N, Gonzalez-Alegre P, Elman LB, Quinn C, Scherer SS, Amado DA.: The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular Clinics. American Neurological Association Annual Meeting, Philadelphia, PA, September 2023. : 2023.
Defne A. Amado, Alejandro Mas Monteys, Alicia R. Smith, Katherine Whiteman, Guillem Chillon Bosch, Ashley Robbins, Aleksandar Izda, Shareen Nelson, Abigail I. Dichter, Beverly L. Davidson: Improved Survival, Strength, and Neuroinflammation in a Mouse Model of Sporadic ALS after Novel AAV-Mediated Delivery of RNAi Targeting Atxn2. American Neurological Association Annual Meeting, Philadelphia, PA, September 2023. : 2023.
Johnson K, Azage M, Babaian N, Baldwin A, Dratch L, Paul R, Bardakjian TM, Amado DA, Elman LB, Gonzalez-Alegre P, Hamedani A, Quinn C, Ellis C, Scherer SS.: Genetic Testing Trends in Adult Neurology: Increasing Access and Evolving Yield. American Neurological Association Annual Meeting, Philadelphia, PA, September 2023. : 2023.
Amado DA, Robbins A.: The Emerging Landscape of Targeted Therapeutics for Genetic Neuromuscular Disorders. Practical Neurology : 2023.
Defne A. Amado, Alejandro Mas Monteys, Katherine Whiteman, Alicia R. Smith, Guillem Chillon Bosch, Aleksandar Izda, Beverly L. Davidson: Novel AAV-Capsid-Mediated Delivery of an RNAi Targeting Atxn2 Extends Survival and Improves Strength and Neuroinflammation in a Mouse Model of Sporadic ALS American Society of Gene and Cell Therapy Annual Meeting, Los Angeles, CA : 2023.
Dawicki-McKenna J, Felix A, Waxman E, Cheng C, Amado DA, Ranum PT, Bogush A, Dungan LV, Maguire JA, Gagne AL, Heller EA, French DL, Davidson BL, Prosser B.: Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching. Nature Communications 14 (1): 2628,2023.
Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik AF, Elman LB, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA.: Disparities in genetic testing for neurologic disorders. Neurology : 2023.
Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon S, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA.: Genetic testing in adults with neurological disorders: Indications, approach, and clinical impacts. Journal of Neurology : 2023.
View all publications
Academic Contact Information
3W Gates
3400 Spruce Street
Philadelphia,
PA
19104
Patient appointments: 800-789-7366